Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q1 Loss of $0.20
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $84.00 -2.03%
EPS Growth %: +4.8%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
CCEL, SLP, TMQ, More
EPS Growth %: +4.8%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($0.20), versus ($0.03) reported last year. Revenue for the quarter came in at $21.3 million, versus $29.46 million reported last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Carmila agrees to buy Dijon shopping centre for €45 million
- VerticalScope invests $6.1M in Canadian AI firm AltaML
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
